Effect of baroreflex activation therapy on home blood pressure measurements after long-term therapy – a prospective, randomized crossover study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010221

Enrollment

Registered

2017-07-18

Start date

2016-12-06

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Therapy resistant hypertension I10

Interventions

Group 1: Randomized de- and reactivation of BAT device prior to a scheduled device replacement

group 1: deactivation period followed by reactivation period Group 2: Randomized de- and reactivation of BAT device prior to a scheduled device replacement

group 2: activation period followed by deactivation period

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - resistant hypertension, secondary causes of hypertension have been excluded - barostimulation with low battery status - written consent to participate in the trial after the patient has been informed of the content of the trial in writing and in person

Exclusion criteria

Exclusion criteria: - battery replacement of the barostimulation device not possible at the moment because of medical or other reasons - therapeutic effect of the barostimulation therapy has already been proven in this patient

Design outcomes

Primary

Measure	Time frame
Change in telemetric home blood pressure	—

Secondary

Measure	Time frame
Change in office blood pressure	—

Countries

Germany

Contacts

Public ContactMarcel Halbach

Universitätsklinik Köln, Kardiologie

marcel.halbach@uk-koeln.de0221 / 478 97177

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026